Skip to main content

Published locations for ASCO: PERSIST-1 – pacritinib tops best available therapy in myelofibrosis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ASCO: PERSIST-1 – pacritinib tops best available therapy in myelofibrosis

User login

  • Reset your password
  • /content/asco-persist-1-pacritinib-tops-best-available-therapy-myelofibrosis
  • /hematologynews/article/100228/rare-diseases/asco-persist-1-pacritinib-tops-best-available-therapy
  • /oncologypractice/article/100228/rare-diseases/asco-persist-1-pacritinib-tops-best-available-therapy
  • /hematology-oncology/article/100228/rare-diseases/asco-persist-1-pacritinib-tops-best-available